BIOMAT Database Logo BIOMAT Database Logo

Bacterial resistance to norfloxacin and other newer quinolones: pattern and prospects. 1988

D R Nalin
Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D011804 Quinolines
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D R Nalin
Fixed drug eruption due to norfloxacin and cross-reactivity with other quinolones.
January 2013, Allergologia et immunopathologia,
D R Nalin
[Mechanisms of bacterial resistance to quinolones].
October 1996, Nihon saikingaku zasshi. Japanese journal of bacteriology,
D R Nalin
[Mechanisms of bacterial resistance to quinolones].
March 2002, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
D R Nalin
[Therapy of urinary tract infections. Clinical experience comparing norfloxacin to other quinolones].
January 1990, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
D R Nalin
Bacterial resistance to quinolones: mechanisms and clinical importance.
January 1989, Reviews of infectious diseases,
D R Nalin
The epidemiology of bacterial resistance to quinolones.
January 1993, Drugs,
D R Nalin
Emerging bacterial resistance to the newer cephalosporins.
May 1984, The Journal of antimicrobial chemotherapy,
D R Nalin
Rapid Detection of Bacterial Susceptibility or Resistance to Quinolones.
January 2017, Methods in molecular biology (Clifton, N.J.),
D R Nalin
Susceptibility of the Bacteroides fragilis group to newer quinolones and other standard anti-anaerobic agents.
July 2001, The Journal of antimicrobial chemotherapy,
D R Nalin
Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.
November 1991, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!